Kevin Slater

Loading
Kevin Slater

Kevin Slater

CEO And Founder, Praecis Dx Ltd
CEO, previously founded and exited two biotech companies, LumiTech and PetScreen. LumiTech was sold to the Cambrex Corp, in 2000. He is author of six international patents for novel testing methods which now belong to Lonza. PetScreen was a company identifying novel biomarkers associated with acute and chronic veterinary disease also provided resultant novel testing services based on these biomarkers to vets in practice. He is a pioneer of combining multiple biomarker tests using algorithms for the veterinary sector. PetScreen was sold to Avacta Animal Health in 2013. Dr Slater was the Chief Scientific Officer for Avacta until October 2017.
Sessions

Sponsors & Partners

Platinum Sponsor

  • Elanco

Silver Sponsor

  • Boehringer Ingelheim
  • Virbac

Silver Sponsor

  • Medivet

Media Partner

  • Vet Record

Media Partner

  • In Practice

Media Partner

  • Vet Surgeon

Education Partner

  • Central CPD

Newsletter Sign-Up

Be the first to hear the latest news, programme updates and exclusive industry releases.